Stroke: secondary prevention

First Page		Document Content
Date: 2013-03-18 10:21:10 Bristol-Myers Squibb Ketones Stroke Cardiac electrophysiology Management of atrial fibrillation Dabigatran Warfarin Rivaroxaban Transient ischemic attack Chemistry Organic chemistry Anticoagulants		Stroke: secondary prevention Add to Reading List Source URL: inami.fgov.be Download Document from Source Website File Size: 2,08 MB Share Document on Facebook

	* Drug Safety Alert * Xarelto (Rivaroxaban) Tablets FDA MedWatch - August 2013 Safety Labeling Changes with revisions to Prescribing Information [PostedThe MedWatch August 2013 Safety Labeling Changes po DocID: 1t7rk - View Document
	Microsoft Word - frommtg draft uspi xarelto rivaroxaban.doc DocID: 1sPZ1 - View Document
	MEDICATION GUIDE XARELTO® (zah-REL-toe) (rivaroxaban) tablets Read this Medication Guide before you start taking XARELTO and each time you get a refill. There may be new information. This Medication Guide does not take DocID: 1scq8 - View Document
	Atrial Fibrillation (AFib) Treatment Adherence Following your treatment plan will reduce your risk of AFib-related stroke. it can enter the bloodstream and cause a stroke. A stroke means DocID: 1pjDF - View Document
	QuarterWatch Monitoring FDA MedWatch Reports Why Reports of Serious Adverse Drug Events Continue to Grow October 3, 2012 Data from 2012 Quarter 1 DocID: 1p1ui - View Document